Sarepta Therapeutics (SRPT) PT Lowered to $160 at Needham & Company

March 17, 2023 6:22 AM EDT Send to a Friend

Needham & Company analyst Gil ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Sarepta Therapeutics (SRPT) PT Lowered to $160 at Needham & Company

Member Login

Free News Feed